Macgregor I R, Miller W R
Scottish National Blood Transfusion Service, Headquarters Unit Laboratory, Edinburgh, U.K.
Eur J Cancer Clin Oncol. 1988 Jun;24(6):985-9. doi: 10.1016/0277-5379(88)90147-2.
Breast cyst fluids obtained by needle aspiration from 20 patients were analysed for the presence of urokinase-like (u-PA) and tissue-type (t-PA) plasminogen activators. Plasminogen, the natural substrate for these PAs, was also measured. u-PA activity was detected in 18 samples (mean +/- S.D. = 1.11 +/- 1.08 IU ml-1) and t-PA activity in 16 samples (0.35 +/- 0.28 IU ml-1). Plasminogen was detected in 10 samples (mean = 37 micrograms ml-1), range 28-85 micrograms ml-1) and was below the assay detection limit in the other samples. While both u-PA and t-PA specific activities were greater in the 10 cyst fluids categorized as Group A (Na+ to K+ concentration ratio less than 4) than in the 10 samples categorized in Group B (Na+ to K+ concentration ratio greater than 4), the differences were not statistically significant. Nevertheless, this is the first evidence that u-PA and t-PA are present in active forms in breast cyst fluids. The significance of such activities must be hypothetical, but it is possible that a study of factors influencing the levels of u-PA and t-PA within the breast may yield information about pathophysiology of cystic and other diseases of the breast.
对通过针吸从20名患者获取的乳腺囊肿液进行分析,以检测是否存在尿激酶样(u-PA)和组织型(t-PA)纤溶酶原激活剂。还对这些纤溶酶原激活剂的天然底物纤溶酶原进行了测量。在18个样本中检测到u-PA活性(平均值±标准差=1.11±1.08 IU ml-1),在16个样本中检测到t-PA活性(0.35±0.28 IU ml-1)。在10个样本中检测到纤溶酶原(平均值=37微克ml-1,范围28 - 85微克ml-1),其他样本中的纤溶酶原低于检测限。虽然在归类为A组的10份囊肿液(钠钾浓度比小于4)中,u-PA和t-PA的比活性均高于归类为B组的10个样本(钠钾浓度比大于4),但差异无统计学意义。然而,这是u-PA和t-PA以活性形式存在于乳腺囊肿液中的首个证据。此类活性的意义必然是假设性的,但研究影响乳腺内u-PA和t-PA水平的因素可能会得出有关乳腺囊性及其他疾病病理生理学的信息。